
Ultragef 250mg Tablet
Marketer
Bangalore Antibiotics & Biologicals Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Ultragef 250mg Tablet
Afgetium 250mg tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should follow your physician's instructions; continue treatment as directed. Treatment length depends on individual response. Regular liver function monitoring may be advised. Common side effects are diarrhea, dry skin, anorexia, and nausea. Increased fluid intake may lessen side effects. Report any bothersome or worsening side effects. Immediately contact your doctor if you experience oral ulceration, visual changes, or respiratory distress. Women should utilize effective contraception during and for one month after treatment to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Primary Ingredients of Ultragef 250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ultragef 250mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Ultragef 250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ultragef 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ultragef 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Ultragef 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ultragef 250mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Ultragef 250mg Tablet works:
Oncasin 250mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a defective protein responsible for cancerous cell proliferation, thus hindering or reducing tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ultragef 250mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ultragef 250mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Ultragef 250mg Tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Ultragef 250mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Ultragef 250mg Tablets. Dosage modification of Ultragef 250mg Tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver disease can likely use Ultragef 250mg Tablets safely. Available evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Ultragef 250mg Tablet :
Omit any missed Ultragef 250mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Ultragef 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
